Month: July 2024

FDA Implements Final Rule for Regulating Laboratory Developed Tests as In Vitro Diagnostic Devices

FDA Implements Final Rule for Regulating Laboratory Developed Tests as In Vitro Diagnostic Devices

The FDA has declared a Final Rule to phase out the enforcement discretion for laboratory developed tests (LDTs), aligning them with the regulatory framework applied to in vitro diagnostics (IVDs). This change, to be published in the Federal Register on May 6, 2024, and available in a PDF version beforehand, signifies a significant shift for […]

Continue Reading

FDA Collaborates with Gates Foundation to Advance Development of Breath-Based Diagnostics

FDA Collaborates with Gates Foundation to Advance Development of Breath-Based Diagnostics

The FDA’s Center for Devices and Radiological Health has entered into a partnership with the Bill and Melinda Gates Foundation to enhance diagnostic development, supported by a $1.9 million grant from the Gates Foundation. This collaboration aims to devise novel analytical methods geared towards the advancement of breath-based diagnostic tools specifically designed for diseases prevalent […]

Continue Reading